世界の急性呼吸窮迫症候群治療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acute Respiratory Distress Syndrome Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3760
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、急性呼吸窮迫症候群治療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（メチルプレドニゾロン、ヒドロコルチゾン、注射用ウシ肺サーファクタント、その他）、用途別市場規模（入院患者、外来患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・急性呼吸窮迫症候群治療法の市場動向
・企業の競争状況、市場シェア
・急性呼吸窮迫症候群治療法の種類別市場規模と予測2016-2027（メチルプレドニゾロン、ヒドロコルチゾン、注射用ウシ肺サーファクタント、その他）
・急性呼吸窮迫症候群治療法の用途別市場規模と予測2016-2027（入院患者、外来患者）
・急性呼吸窮迫症候群治療法の北米市場規模2016-2027（アメリカ、カナダ）
・急性呼吸窮迫症候群治療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・急性呼吸窮迫症候群治療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・急性呼吸窮迫症候群治療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・急性呼吸窮迫症候群治療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Therabron Therapeutics, Inc.、Serendex Pharmaceuticals A/S、Silence Therapeutics Plc、Histocell S.L.、Altor BioScience Corporation、Athersys, Inc.、Faron Pharmaceuticals Oy、FirstString Research, Inc.、GlaxoSmithKline Plc、Phylogica Limited）
・結論

Market Analysis and Insights: Global Acute Respiratory Distress Syndrome Therapeutics Market
The global Acute Respiratory Distress Syndrome Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Respiratory Distress Syndrome Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Respiratory Distress Syndrome Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Respiratory Distress Syndrome Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Respiratory Distress Syndrome Therapeutics market.

Global Acute Respiratory Distress Syndrome Therapeutics Scope and Market Size
Acute Respiratory Distress Syndrome Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Respiratory Distress Syndrome Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Methylprednisolone
Hydrocortisone
Calf Pulmonary Surfactant for Injection
Others

Segment by Application
In-Patient
Out-Patient

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Therabron Therapeutics, Inc.
Serendex Pharmaceuticals A/S
Silence Therapeutics Plc
Histocell S.L.
Altor BioScience Corporation
Athersys, Inc.
Faron Pharmaceuticals Oy
FirstString Research, Inc.
GlaxoSmithKline Plc
Phylogica Limited

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Methylprednisolone
1.2.3 Hydrocortisone
1.2.4 Calf Pulmonary Surfactant for Injection
1.2.5 Others
1.3 Market by Application
1.3.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 In-Patient
1.3.3 Out-Patient
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Perspective (2016-2027)
2.2 Acute Respiratory Distress Syndrome Therapeutics Growth Trends by Regions
2.2.1 Acute Respiratory Distress Syndrome Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Respiratory Distress Syndrome Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Acute Respiratory Distress Syndrome Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Acute Respiratory Distress Syndrome Therapeutics Industry Dynamic
2.3.1 Acute Respiratory Distress Syndrome Therapeutics Market Trends
2.3.2 Acute Respiratory Distress Syndrome Therapeutics Market Drivers
2.3.3 Acute Respiratory Distress Syndrome Therapeutics Market Challenges
2.3.4 Acute Respiratory Distress Syndrome Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Respiratory Distress Syndrome Therapeutics Players by Revenue
3.1.1 Global Top Acute Respiratory Distress Syndrome Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Respiratory Distress Syndrome Therapeutics Revenue
3.4 Global Acute Respiratory Distress Syndrome Therapeutics Market Concentration Ratio
3.4.1 Global Acute Respiratory Distress Syndrome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Respiratory Distress Syndrome Therapeutics Revenue in 2020
3.5 Acute Respiratory Distress Syndrome Therapeutics Key Players Head office and Area Served
3.6 Key Players Acute Respiratory Distress Syndrome Therapeutics Product Solution and Service
3.7 Date of Enter into Acute Respiratory Distress Syndrome Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Respiratory Distress Syndrome Therapeutics Breakdown Data by Type
4.1 Global Acute Respiratory Distress Syndrome Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Acute Respiratory Distress Syndrome Therapeutics Forecasted Market Size by Type (2022-2027)

5 Acute Respiratory Distress Syndrome Therapeutics Breakdown Data by Application
5.1 Global Acute Respiratory Distress Syndrome Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Acute Respiratory Distress Syndrome Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Respiratory Distress Syndrome Therapeutics Market Size (2016-2027)
6.2 North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Type
6.2.1 North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2027)
6.3 North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Application
6.3.1 North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2016-2027)
6.4 North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country
6.4.1 North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Acute Respiratory Distress Syndrome Therapeutics Market Size (2016-2027)
7.2 Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Type
7.2.1 Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2027)
7.3 Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Application
7.3.1 Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2016-2027)
7.4 Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Country
7.4.1 Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Type
8.2.1 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Application
8.3.1 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Region
8.4.1 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size (2016-2027)
9.2 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Type
9.2.1 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Application
9.3.1 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country
9.4.1 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Type
10.2.1 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Application
10.3.1 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Country
10.4.1 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Therabron Therapeutics, Inc.
11.1.1 Therabron Therapeutics, Inc. Company Details
11.1.2 Therabron Therapeutics, Inc. Business Overview
11.1.3 Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Introduction
11.1.4 Therabron Therapeutics, Inc. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
11.1.5 Therabron Therapeutics, Inc. Recent Development
11.2 Serendex Pharmaceuticals A/S
11.2.1 Serendex Pharmaceuticals A/S Company Details
11.2.2 Serendex Pharmaceuticals A/S Business Overview
11.2.3 Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Introduction
11.2.4 Serendex Pharmaceuticals A/S Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
11.2.5 Serendex Pharmaceuticals A/S Recent Development
11.3 Silence Therapeutics Plc
11.3.1 Silence Therapeutics Plc Company Details
11.3.2 Silence Therapeutics Plc Business Overview
11.3.3 Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Introduction
11.3.4 Silence Therapeutics Plc Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
11.3.5 Silence Therapeutics Plc Recent Development
11.4 Histocell S.L.
11.4.1 Histocell S.L. Company Details
11.4.2 Histocell S.L. Business Overview
11.4.3 Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Introduction
11.4.4 Histocell S.L. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
11.4.5 Histocell S.L. Recent Development
11.5 Altor BioScience Corporation
11.5.1 Altor BioScience Corporation Company Details
11.5.2 Altor BioScience Corporation Business Overview
11.5.3 Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Introduction
11.5.4 Altor BioScience Corporation Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
11.5.5 Altor BioScience Corporation Recent Development
11.6 Athersys, Inc.
11.6.1 Athersys, Inc. Company Details
11.6.2 Athersys, Inc. Business Overview
11.6.3 Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Introduction
11.6.4 Athersys, Inc. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
11.6.5 Athersys, Inc. Recent Development
11.7 Faron Pharmaceuticals Oy
11.7.1 Faron Pharmaceuticals Oy Company Details
11.7.2 Faron Pharmaceuticals Oy Business Overview
11.7.3 Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Introduction
11.7.4 Faron Pharmaceuticals Oy Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
11.7.5 Faron Pharmaceuticals Oy Recent Development
11.8 FirstString Research, Inc.
11.8.1 FirstString Research, Inc. Company Details
11.8.2 FirstString Research, Inc. Business Overview
11.8.3 FirstString Research, Inc. Acute Respiratory Distress Syndrome Therapeutics Introduction
11.8.4 FirstString Research, Inc. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
11.8.5 FirstString Research, Inc. Recent Development
11.9 GlaxoSmithKline Plc
11.9.1 GlaxoSmithKline Plc Company Details
11.9.2 GlaxoSmithKline Plc Business Overview
11.9.3 GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Introduction
11.9.4 GlaxoSmithKline Plc Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
11.9.5 GlaxoSmithKline Plc Recent Development
11.10 Phylogica Limited
11.10.1 Phylogica Limited Company Details
11.10.2 Phylogica Limited Business Overview
11.10.3 Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Introduction
11.10.4 Phylogica Limited Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
11.10.5 Phylogica Limited Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Respiratory Distress Syndrome Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Methylprednisolone
Table 3. Key Players of Hydrocortisone
Table 4. Key Players of Calf Pulmonary Surfactant for Injection
Table 5. Key Players of Others
Table 6. Global Acute Respiratory Distress Syndrome Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acute Respiratory Distress Syndrome Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Acute Respiratory Distress Syndrome Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Acute Respiratory Distress Syndrome Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Regions (2022-2027)
Table 12. Acute Respiratory Distress Syndrome Therapeutics Market Trends
Table 13. Acute Respiratory Distress Syndrome Therapeutics Market Drivers
Table 14. Acute Respiratory Distress Syndrome Therapeutics Market Challenges
Table 15. Acute Respiratory Distress Syndrome Therapeutics Market Restraints
Table 16. Global Acute Respiratory Distress Syndrome Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Acute Respiratory Distress Syndrome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Respiratory Distress Syndrome Therapeutics as of 2020)
Table 19. Ranking of Global Top Acute Respiratory Distress Syndrome Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Acute Respiratory Distress Syndrome Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Acute Respiratory Distress Syndrome Therapeutics Product Solution and Service
Table 23. Date of Enter into Acute Respiratory Distress Syndrome Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Acute Respiratory Distress Syndrome Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Acute Respiratory Distress Syndrome Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Acute Respiratory Distress Syndrome Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Therabron Therapeutics, Inc. Company Details
Table 64. Therabron Therapeutics, Inc. Business Overview
Table 65. Therabron Therapeutics, Inc. Acute Respiratory Distress Syndrome Therapeutics Product
Table 66. Therabron Therapeutics, Inc. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Therabron Therapeutics, Inc. Recent Development
Table 68. Serendex Pharmaceuticals A/S Company Details
Table 69. Serendex Pharmaceuticals A/S Business Overview
Table 70. Serendex Pharmaceuticals A/S Acute Respiratory Distress Syndrome Therapeutics Product
Table 71. Serendex Pharmaceuticals A/S Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Serendex Pharmaceuticals A/S Recent Development
Table 73. Silence Therapeutics Plc Company Details
Table 74. Silence Therapeutics Plc Business Overview
Table 75. Silence Therapeutics Plc Acute Respiratory Distress Syndrome Therapeutics Product
Table 76. Silence Therapeutics Plc Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Silence Therapeutics Plc Recent Development
Table 78. Histocell S.L. Company Details
Table 79. Histocell S.L. Business Overview
Table 80. Histocell S.L. Acute Respiratory Distress Syndrome Therapeutics Product
Table 81. Histocell S.L. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Histocell S.L. Recent Development
Table 83. Altor BioScience Corporation Company Details
Table 84. Altor BioScience Corporation Business Overview
Table 85. Altor BioScience Corporation Acute Respiratory Distress Syndrome Therapeutics Product
Table 86. Altor BioScience Corporation Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Altor BioScience Corporation Recent Development
Table 88. Athersys, Inc. Company Details
Table 89. Athersys, Inc. Business Overview
Table 90. Athersys, Inc. Acute Respiratory Distress Syndrome Therapeutics Product
Table 91. Athersys, Inc. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Athersys, Inc. Recent Development
Table 93. Faron Pharmaceuticals Oy Company Details
Table 94. Faron Pharmaceuticals Oy Business Overview
Table 95. Faron Pharmaceuticals Oy Acute Respiratory Distress Syndrome Therapeutics Product
Table 96. Faron Pharmaceuticals Oy Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Faron Pharmaceuticals Oy Recent Development
Table 98. FirstString Research, Inc. Company Details
Table 99. FirstString Research, Inc. Business Overview
Table 100. FirstString Research, Inc. Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 101. FirstString Research, Inc. Recent Development
Table 102. GlaxoSmithKline Plc Company Details
Table 103. GlaxoSmithKline Plc Business Overview
Table 104. GlaxoSmithKline Plc Acute Respiratory Distress Syndrome Therapeutics Product
Table 105. GlaxoSmithKline Plc Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 106. GlaxoSmithKline Plc Recent Development
Table 107. Phylogica Limited Company Details
Table 108. Phylogica Limited Business Overview
Table 109. Phylogica Limited Acute Respiratory Distress Syndrome Therapeutics Product
Table 110. Phylogica Limited Revenue in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 111. Phylogica Limited Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Methylprednisolone Features
Figure 3. Hydrocortisone Features
Figure 4. Calf Pulmonary Surfactant for Injection Features
Figure 5. Others Features
Figure 6. Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. In-Patient Case Studies
Figure 8. Out-Patient Case Studies
Figure 9. Acute Respiratory Distress Syndrome Therapeutics Report Years Considered
Figure 10. Global Acute Respiratory Distress Syndrome Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Acute Respiratory Distress Syndrome Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Acute Respiratory Distress Syndrome Therapeutics Market Share by Players in 2020
Figure 15. Global Top Acute Respiratory Distress Syndrome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Respiratory Distress Syndrome Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Acute Respiratory Distress Syndrome Therapeutics Revenue in 2020
Figure 17. Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Acute Respiratory Distress Syndrome Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Acute Respiratory Distress Syndrome Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Acute Respiratory Distress Syndrome Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Acute Respiratory Distress Syndrome Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acute Respiratory Distress Syndrome Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Acute Respiratory Distress Syndrome Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Acute Respiratory Distress Syndrome Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Acute Respiratory Distress Syndrome Therapeutics Market Share by Region (2016-2027)
Figure 39. China Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acute Respiratory Distress Syndrome Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Acute Respiratory Distress Syndrome Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Acute Respiratory Distress Syndrome Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Acute Respiratory Distress Syndrome Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Acute Respiratory Distress Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Therabron Therapeutics, Inc. Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
Figure 59. Serendex Pharmaceuticals A/S Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
Figure 60. Silence Therapeutics Plc Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
Figure 61. Histocell S.L. Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
Figure 62. Altor BioScience Corporation Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
Figure 63. Athersys, Inc. Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
Figure 64. Faron Pharmaceuticals Oy Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
Figure 65. FirstString Research, Inc. Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
Figure 66. GlaxoSmithKline Plc Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
Figure 67. Phylogica Limited Revenue Growth Rate in Acute Respiratory Distress Syndrome Therapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4854 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、重症急性呼吸器症候群（SARS）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CEL-1000、D-3252、FDX-000、INO-4500、LCA-60、その他）、用途別市場規模（病院、ク...

急性呼吸窮迫症候群(ARDS)治療薬のグローバル市場調査 2019年

Global Acute Respiratory Distress Syndrome Therapeutics Market Professional Survey Report 2019
QYR9NV00152 2019年11月12日 102Pages
※本調査レポートは、急性呼吸窮迫症候群(ARDS)治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、メチルプレドニゾロン、ヒドロコルチゾン、注射用子牛肺サ...

世界の小児呼吸器疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Pediatric Respiratory Disease Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4675 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、小児呼吸器疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、気管支拡張薬、併用薬、コルチコステロイド、モノクローナル抗体、その他）、用途別市場規模（喘息、嚢胞性線維症、細気管支炎、肺...

世界の急性興奮＆攻撃性治療市場規模・現状・予測（2021年-2027年）

Global Acute Agitation and Aggression Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5563 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、急性興奮＆攻撃性治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、筋肉内注射、その他）、用途別市場規模（病院＆外来手術室、精神科医療施設、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の呼吸器合胞体ウイルス（RSV）治療薬市場規模・現状・予測（2021年-2027年）

Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5991 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、呼吸器合胞体ウイルス（RSV）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（パリビズマブ、リバビリン、その他）、用途別市場規模（病院薬局、ドラッグストア、小売薬局、その他）、主要地域別市場規模...

世界の急性腎障害治療法市場規模・現状・予測（2021年-2027年）

Global Acute Kidney Injury Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5566 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、急性腎障害治療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非薬物式、薬物式）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界のアッシャー症候群治療薬市場規模・現状・予測（2021年-2027年）

Global Usher Syndrome Threapeutics Market Size, Status and Forecast 2021-2027
QFJ1-5003 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アッシャー症候群治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NT-501、QRX-411、QRX-421、SAR-421869、その他）、用途別市場規模（クリニック、病院、その他）、主要地域...

世界の多嚢胞性卵巣症候群（PCOS）治療薬市場規模・現状・予測（2021年-2027年）

Global Polycystic Ovarian Syndrome (PCOS) Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4731 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口避妊薬、排卵誘発剤、顔面発毛阻害剤、インスリン感作剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界の閉塞性細気管支炎症候群市場規模・現状・予測（2021年-2027年）

Global Bronchiolitis Obliterans Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-3944 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、閉塞性細気管支炎症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（吸入式、経口式）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

急性呼吸窮迫症候群(ARDS)治療薬のグローバル市場調査 2019年 The global Acute Respiratory Distress Syndrome Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Acute Respiratory Distress Syndrome Therapeutics volume and value at global level, regiona…
世界の重症急性呼吸器症候群（SARS）治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Market The global Severe Acute Respiratory Syndrome(SARS) Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-sta…
世界の小児呼吸器疾患治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pediatric Respiratory Disease Therapeutics Market The global Pediatric Respiratory Disease Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…
世界の急性興奮＆攻撃性治療市場規模・現状・予測（2021年-2027年） With acute agitation and aggression being a common symptom among patients suffering from various types of mental illnesses, the healthcare industry is expending efforts towards developing effective panaceas. Market Analysis and Insights: Global Acute Agitation and Aggression Therapeutics Market The …
世界の急性腎障害治療法市場規模・現状・予測（2021年-2027年） Acute kidney injury therapeutics is the cure to the acute kidney injury that is a group of clinical syndromes that refers to sudden (within 1-7d) and sustained (> 24h) sudden declines in renal function. It is defined as an increase in serum creatinine (SCr) of at least 0.5mg / dl 1 and manifested as…